Efficacy and safety of AZD7594, an inhaled non-steroidal selective glucocorticoid receptor modulator, in patients with asthma: a phase 2a randomized, double blind, placebo-controlled crossover trial

Table 5 AUEC0‐24 for plasma cortisol on Day 14

Dose	n	Geometric mean ratio to baseline compared to placebo (95% CI)	p‐value
placebo	14
58 μg	9	1.03 (0.90‐1.19)	0.6342
250 μg	9	1.02 (0.88‐1.18)	0.7620
800 μg	9	0.91 (0.79‐1.05)	0.2008

AUEC 0‐24 Area under plasma concentration time curve from time zero to 24 hours after dose administration, CI confidence Interval

ISSN: 1465-993X